Equifax CFO sells 4,500 shares at $187.96

Equifax’s EVP, CFO & COO executed a 4,500‑share planned sale and now directly holds 69,055 shares including dividend equivalents.

Available on EDGAR 09/08/2026 - 04:08 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

EQUIFAX INC (EFX) executive John W. Gamble Jr., EVP, CFO & COO, sold 4,500 shares of common stock in an open-market transaction on September 3, 2026 at $187.96 per share, under a Rule 10b5-1 trading plan adopted on May 28, 2026.

After this sale, he directly holds 69,055 shares, which include accrued dividend equivalent units associated with restricted stock units.

Insider Trade Summary 10b5-1

Net Seller: 4,500 shares

Net Sell 1 txn

Insider GAMBLE JOHN W JR

Role EVP, CFO & COO

Sold 4,500 shs ($846K)

Share of Position Sold 6.1%

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	4,500	$187.96	$846K

Holdings After Transaction: Common Stock — 69,055 shares (Direct)

Holdings Before and After: Common Stock, 73,555 to 69,055 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026.
2. F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Key Figures

Shares sold: 4,500 shares Sale price per share: $187.96 per share Shares held after transaction: 69,055 shares +1 more

4 metrics

Shares sold 4,500 shares Open-market sale of Equifax common stock on September 3, 2026

Sale price per share $187.96 per share Price received for Equifax common stock on September 3, 2026

Shares held after transaction 69,055 shares Direct holdings of John W. Gamble Jr. after the September 3, 2026 sale

Rule 10b5-1 plan adoption date May 28, 2026 Adoption date of the trading plan used for the September 3, 2026 sale

Key Terms

Rule 10b5-1 trading plan, dividend equivalent units, restricted stock units

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

dividend equivalent units financial

"Includes accrued dividend equivalent units for dividends reinvested"

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

restricted stock units financial

"dividends reinvested in corresponding restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Equifax (EFX) report for John W. Gamble Jr.?

Equifax reported that John W. Gamble Jr., its EVP, CFO & COO, sold 4,500 shares of common stock on September 3, 2026 in an open-market transaction at $187.96 per share, executed under a Rule 10b5-1 trading plan.

How many Equifax (EFX) shares does John W. Gamble Jr. hold after this Form 4 transaction?

After the reported sale, John W. Gamble Jr. directly holds 69,055 shares of Equifax common stock. This amount includes dividend equivalent units tied to restricted stock units through the company’s last dividend payment date.

Was the Equifax (EFX) insider sale by John W. Gamble Jr. under a Rule 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by John W. Gamble Jr. on May 28, 2026, and the Form 4 also affirms Rule 10b5-1 plan status at the document level.

What price did John W. Gamble Jr. receive per Equifax (EFX) share in this sale?

He sold the 4,500 shares of Equifax common stock at a price of $187.96 per share on September 3, 2026, as reported in the Form 4 transaction details.

Does John W. Gamble Jr.’s reported Equifax (EFX) holding include dividend equivalent units?

Yes. The 69,055 shares reported as held after the transaction include accrued dividend equivalent units for dividends that were reinvested in corresponding restricted stock units through Equifax’s last dividend payment date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GAMBLE JOHN W JR

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GEORGIA 30309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2026		S(1)		4,500	D	$187.96	69,055(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

	/s/Lisa Stockard as Attorney-in-Fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)